Immuno-oncology

The rapid development of immuno-oncology therapies for multiple types of cancer has transformed the cancer treatment landscape and brightened the long-term outlook for many patients with advanced cancer. Oncode researchers have significant contributions in this arena both in understanding and advancing better treatments.

Please drop us a line if you want to get in touch with one of our experts.

Oncode Investigators

Radboud UMC

Chemical Immunology, antigen presenting cells, Immunotherapy

NKI

Functional genomics for rational tumor and immune cell combination therapy

NKI

Immune cells and macrophages in therapeutically challenging tumors

Sanquin

T cell effector function, post-transcriptional gene regulation, RNA binding proteins

Amsterdam UMC

GEA, genome-immunome interactions, intratumor heterogeneity, targeted-immunotherapy